EODData

FRA, 4KB: Krystal Biotech Inc

22 Dec 2025
LAST:

204.6

CHANGE:
 7.00
OPEN:
204.6
HIGH:
204.6
ASK:
0.0
VOLUME:
5
CHG(%):
3.54
PREV:
197.6
LOW:
204.6
BID:
0.0
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Dec 25204.6204.6204.6204.65
19 Dec 25197.6197.6197.6197.65
18 Dec 25199.6199.6199.6199.65
17 Dec 25202.6202.6202.6202.65
16 Dec 25205.2205.2205.2205.25
15 Dec 25208.0208.0208.0208.05
12 Dec 25209.7209.8209.7209.85
11 Dec 25203.3206.8203.3206.812
10 Dec 25200.7202.5200.7202.510
09 Dec 25200.0200.0200.0200.013

PROFILE

Name:Krystal Biotech Inc
About:Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Sector:Healthcare
Industry:Biotechnology
Address:2100 Wharton Street, Pittsburgh, PA, United States, 15203
Website:https://www.krystalbio.com
ISIN:US5011471027
LEI:549300YONUY68210OE41

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:29.32 
Forward P/E:-46.42 
PEG Ratio:0.20 
Price to Sales:13.20 
Price to Book:4.32 
Profit Margin:0.53 
Operating Margin:0.42 
Return on Assets:0.09 
Return on Equity:0.20 
Revenue:323.87M 
EBITDA:148.03M 
Shares:28.94M 
Market Cap:5.922B 

TECHNICAL INDICATORS

MA5:201.911.3%
MA10:203.670.5%
MA20:195.674.6%
MA50:179.4214.0%
MA100:155.5131.6%
MA200:144.5441.6%
STO9:57.38
STO14:79.85
RSI14:72.81 
WPR14:-20.16
MTM14:20.60
ROC14:0.11 
ATR:3.22 
Week High:208.001.7%
Week Low:197.603.5%
Month High:209.802.5%
Month Low:183.3541.6%
Year High:209.802.5%
Year Low:107.5090.3%
Volatility:8.66